Wu; Xueling

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Xueling.The latest application filed is for "broadly neutralizing hiv-1 antibodies that bind to the cd4-binding site of the envelope protein".

Company Profile

5.14.16

Wu; Xueling - Potomac MD
Wu; Xueling - Bethesda MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,815,295 - Kwong , et al. October 27, 2	2020-10-27
Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing Grant 10,273,291 - Mascola , et al.	2019-04-30
Broadly Neutralizing Hiv-1 Antibodies That Bind To The Cd4-binding Site Of The Envelope Protein App 20190016786 - Kwong; Peter D. ; et al.	2019-01-17
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 10,035,844 - Kwong , et al. July 31, 2	2018-07-31
Neutralizing antibodies to HIV-1 and their use Grant 10,035,845 - Mascola , et al. July 31, 2	2018-07-31
Neutralizing Antibodies To Hiv-1 And Their Use App 20170369558 - Mascola; John ; et al.	2017-12-28
HIV-1 broadly neutralizing antibodies Grant 9,796,774 - Mascola , et al. October 24, 2	2017-10-24
Neutralizing Antibodies To Hiv-1 And Their Use App 20170267748 - Kwong; Peter D. ; et al.	2017-09-21
Neutralizing antibodies to HIV-1 and their use Grant 9,738,703 - Mascola , et al. August 22, 2	2017-08-22
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein Grant 9,695,230 - Kwong , et al. July 4, 2	2017-07-04
Cd4-mimetic Small Molecules Sensitize Human Immunodeficiency Virus To Vaccine-elicited Antibodies App 20160362478 - SODROSKI; Joseph ; et al.	2016-12-15
Novel Hiv -1 Broadly Neutralizing Antibodies App 20160289305 - Mascola; John ; et al.	2016-10-06
CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof Grant 9,403,763 - Sodroski , et al. August 2, 2	2016-08-02
HIV-1 broadly neutralizing antibodies Grant 9,382,311 - Mascola , et al. July 5, 2	2016-07-05
Neutralizing Antibodies To Hiv-1 And Their Use App 20160009789 - Mascola; John ; et al.	2016-01-14
Neutralizing antibodies to HIV-1 and their use Grant 9,175,070 - Mascola , et al. November 3, 2	2015-11-03
Neutralizing Antibodies To Hiv-1 And Their Use App 20150044137 - Mascola; John R. ; et al.	2015-02-12
Cd4-mimetic Inhibitors Of Hiv-1 Entry And Methods Of Use Thereof App 20140350113 - Sodroski; Joseph ; et al.	2014-11-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20140322163 - Kwong; Peter D. ; et al.	2014-10-30
Focused Evolution Of Hiv-1 Neutralizing Antibodies Revealed By Crystal Structures And Deep Sequencing App 20140205607 - Mascola; John R. ; et al.	2014-07-24
Neutralizing antibodies to HIV-1 and their use Grant 8,637,036 - Mascola , et al. January 28, 2	2014-01-28
Novel Hiv -1 Broadly Neutralizing Antibodies App 20130251726 - Mascola; John ; et al.	2013-09-26
Neutralizing Antibodies To Hiv-1 And Their Use App 20120282264 - Mascola; John R. ; et al.	2012-11-08
Neutralizing Antibodies To Hiv-1 And Their Use App 20120244166 - Mascola; John R. ; et al.	2012-09-27
Neutralizing Antibodies To Hiv-1 And Their Use App 20120237523 - Mascola; John R. ; et al.	2012-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.